(S)-4-Chloro-1,1-difluoro-7-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-9-(2,2,2-trifluoro-ethyl)-1,3,6,7,9,10-hexahydro-3,9-diaza-cyclohepta[e]indene-2,8-dione

ID: ALA4873378

PubChem CID: 164620407

Max Phase: Preclinical

Molecular Formula: C30H29ClF5N5O4

Molecular Weight: 654.04

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(C[C@@H]1Cc2cc(Cl)c3c(c2CN(CC(F)(F)F)C1=O)C(F)(F)C(=O)N3)N1CCC(N2CCc3ccccc3NC2=O)CC1

Standard InChI:  InChI=1S/C30H29ClF5N5O4/c31-21-12-17-11-18(26(43)40(15-29(32,33)34)14-20(17)24-25(21)38-27(44)30(24,35)36)13-23(42)39-8-6-19(7-9-39)41-10-5-16-3-1-2-4-22(16)37-28(41)45/h1-4,12,18-19H,5-11,13-15H2,(H,37,45)(H,38,44)/t18-/m0/s1

Standard InChI Key:  SDVHRQIHKWUFFA-SFHVURJKSA-N

Molfile:  

 
     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
   15.5349   -4.5193    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.3244   -3.7310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7470   -4.3075    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.7041   -5.8194    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.5007   -6.0340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2862   -5.2363    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.6774   -3.3596    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0819   -4.0694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8950   -4.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3097   -3.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9011   -2.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0819   -2.6523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8561   -3.3589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4439   -2.6468    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4428   -4.0704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6215   -4.0698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2691   -4.8027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4667   -4.9902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2678   -3.3286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8220   -4.4806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8237   -3.6604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4660   -3.1449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3415   -2.3344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5753   -2.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0608   -3.3676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9371   -2.5559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1267   -2.4198    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7479   -3.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7792   -5.4452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.1283   -3.3727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4855   -2.6377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2886   -2.4574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4812   -4.1160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2830   -4.2999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9312   -2.9633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9266   -3.7854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6357   -4.2007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3498   -3.7909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3504   -2.9657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6408   -2.5582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9745   -1.9926    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2874   -5.7916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3199   -6.8365    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.4480   -1.2311    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   13.9400   -3.2729    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  1  0
  6  5  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 13 15  1  0
 16 15  1  1
 16 17  1  0
 17 18  1  0
 16 19  1  0
 18 20  1  0
 19 22  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 26  1  0
 25 21  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28  2  1  0
  2 25  1  0
 17 29  2  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
 32 35  1  0
 33 34  1  0
 34 36  1  0
 10 30  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 35  1  0
 31 41  2  0
 18 42  1  0
 42  5  1  0
  5 43  1  0
 24 44  1  0
 28 45  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4873378

    ---

Associated Targets(Human)

CALCRL Tclin Calcitonin gene-related peptide type 1 receptor (1509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 654.04Molecular Weight (Monoisotopic): 653.1828AlogP: 4.92#Rotatable Bonds: 4
Polar Surface Area: 102.06Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.18CX Basic pKa: CX LogP: 3.38CX LogD: 3.38
Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.46Np Likeness Score: -0.38

References

1. Luo G, Jiang XJ, Chen L, Conway CM, Gulianello M, Kostich W, Keavy D, Signor LJ, Chen P, Davis C, Whiterock VJ, Schartman R, Widmann KA, Macor JE, Dubowchik GM..  (2021)  Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone lead.,  43  [PMID:33932522] [10.1016/j.bmcl.2021.128077]

Source